logo
Is Aurora Cannabis Inc. (ACB) Among the Best Tobacco and Cigarette Stocks to Buy Now?

Is Aurora Cannabis Inc. (ACB) Among the Best Tobacco and Cigarette Stocks to Buy Now?

Yahoo02-05-2025
We recently compiled a list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against the other Tobacco and Cigarette stocks.
Cigarette and tobacco stocks are companies that produce and sell cigars, snuff, chewing tobacco, cigarettes, e-cigarettes, and all other tobacco products.
The tobacco industry has long been a huge winner for investors. Tobacco companies were among the top performers during the 20th century because of their reputation for providing investors with substantial dividend yields as well as their addictive, extremely profitable, and recession-proof product. However, tobacco firms now confront a different set of challenges. Globally, smoking rates have been progressively declining, particularly in the United States, as a result of growing legislation and health concerns. The industry has attempted to shift to next-generation products as a result. Some people believe that e-cigarettes, vaporizers, and chewable nicotine pouches are healthier options since they avoid some of the negative aspects of smoking cigarettes, such as unpleasant odors. Some companies are expanding beyond tobacco, working with cannabis businesses to capitalize on the potential development in a market that shares numerous similarities with tobacco. There are other hazards associated with tobacco stocks, such as heightened regulation and a decline in smoking rates.
According to the Centers for Disease Control and Prevention, the number of tobacco farms in the United States decreased from 93,530 in 1997 to roughly 3,000 in 2022. Nonetheless, the USA was the world's fifth-largest producer of tobacco in 2021, harvesting 431.6 million pounds in 2022, compared to 1.74 billion pounds in 1997. Seventy-seven percent of U.S. production came from North Carolina or Kentucky. Price reductions accounted for $5.7 billion (72%) of the $8.6 billion tobacco businesses spent on advertising in 2022, which included $572.7 million for smokeless tobacco and $8.01 billion for cigarettes. Marketing costs for e-cigarettes came to $859.4 million in 2021. Sales of cigarette packs fell from 12.5 billion to 9.1 billion packs between 2015 and 2021, a 27% decrease. In 2024, the average cigarette tax in each state was $1.93, while the federal tax was $1.01.
Despite the industry's weak revenue and profit development, investors continue to be drawn to these stocks due to their consistent dividends, profitability, and solid profit margins. Investors believe that stronger growth will eventually be catalyzed by next-generation products.
However, on April 2, 2025, the U.S. Supreme Court upheld the FDA's decision to deny approval for flavored e-cigarettes in a major decision. According to Justice Samuel Alito, vape producers were given 'adequate notice' of the FDA's review criteria. In this case, businesses like Vapetasia and Triton Distribution applied for certification for products such as 'Mother's Milk and Cookies' and 'Killer Kustard Blueberry.'
The FDA has been regulating vaping products since 2016, claiming that flavored vapes represent a health concern and may encourage young people to use tobacco. More than 2.1 million youths in the US reported using e-cigarettes in 2023, with 10% of high school students vaping. The FDA has rejected thousands of flavored products and has only approved tobacco and menthol flavors. One specific issue, marketing plan consideration, was returned to lower courts after the Supreme Court reversed the 5th Circuit's prior criticism of the FDA's changing criteria. Companies that promote unapproved products risk 'civil and criminal penalties,' the FDA warned.
A modern cannabis retail store with a wide selection of products and vaporizers.
For this article, we sifted through the online rankings to form an initial list of the 15 Tobacco and Cigarette Stocks. We have also included e-cigarette and cannabis companies. From the resultant dataset, we chose 10 stocks with the highest number of hedge fund investors, using Insider Monkey's database of 1009 hedge funds in Q4 2024 to gauge hedge fund sentiment for stocks. We have used the stock's market cap as of April 25, 2025, as a tie-breaker in case two or more stocks have the same number of hedge funds invested.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).
Number of Hedge Fund Holders: 6
Aurora Cannabis Inc. (NASDAQ:ACB), a Canadian company with its headquarters located in Edmonton, grows and markets cannabis for both medical and recreational purposes under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company is largely based in Canada, it has expanded globally through medical cannabis export agreements. It is one of the Best Tobacco Stocks.
The third quarter of 2025 was a strong period for Aurora Cannabis Inc. (NASDAQ:ACB), as its earnings per share of $0.41 greatly exceeded forecasts by $0.42. The business produced a record adjusted EBITDA of $23.1 million, up 316% YoY, and a record net income of $31.2 million, up 282% YoY. Furthermore, Q3 revenue exceeded projections by 28.73% YoY to $61.62 million, led by record-breaking global medical net revenue. The company's globalization plan is working; its overseas sales climbed by 112% in the medical cannabis industry. International revenue outpaced Canadian medicinal cannabis for the second consecutive quarter. In 2025, ACB also produced $27.4 million in free cash flow during the third quarter.
Setting new benchmarks in cannabis science, Aurora Cannabis Inc. (NASDAQ:ACB) operates a top-notch genetics and research facility in Canada. The business recently revealed that it has found a new genetic source of resistance to powdery mildew in cannabis sativa, which offers strong protection against this pathogen. The innovation, which is currently being used in its breeding program, provides a vital answer to a major problem facing the cannabis business globally.
Overall, ACB ranks 10th on our list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. While we acknowledge the potential of Tobacco and Cigarette companies, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ACB but that trades at less than 5 times its earnings, check out our report about this .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Super Micro Computer Stock (SMCI) Bulls Eye $100 Price Target
Super Micro Computer Stock (SMCI) Bulls Eye $100 Price Target

Business Insider

time30 minutes ago

  • Business Insider

Super Micro Computer Stock (SMCI) Bulls Eye $100 Price Target

Super Micro Computer (SMCI) has posted an eye-popping 1,677% return over the past five years, yet the stock now sits 57% below its 2024 peak of around $114. Its meteoric rise is being fueled by the AI boom, with its high-performance servers perfectly positioned to meet surging demand. Lately, though, investor sentiment has cooled due to accounting concerns and tightening margins. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Even so, SMCI's strong growth outlook and attractive valuation point to a potential rebound. If the company can navigate near-term challenges, a return to previous highs remains well within reach. Fueling the Surge: The AI Boom Over the past five years, SMCI has ridden the trend of artificial intelligence and data center expansion with its customizable, high-efficiency servers becoming critical for enterprises and hyperscalers scaling AI infrastructure. To quantify this trend, note that from 2020 to 2024, SMCI's revenue soared from $3.34 billion to $15 billion, with a 110.42% year-over-year leap in 2024 alone, driven by partnerships with NVIDIA (NVDA) and AMD (AMD). In the meantime, its U.S.-based manufacturing and leadership in liquid-cooling technology have further solidified its edge, meeting the market's push for sustainable, high-performance solutions. Wall Street has grown increasingly bullish on SMCI, thanks to its ability to deliver modular, scalable systems that have made it a top choice for cloud providers and AI-focused companies. Its inclusion in the NASDAQ 100 in 2023 further elevated its profile and fueled investor optimism. That momentum hasn't faded. With the global data center market projected to hit $528 billion this year and grow at a high-single-digit pace through the decade, SMCI stands to benefit significantly. Its innovative product lineup positions it well to capture a sizable share of this expanding market. SMCI Arrests Stock Market Slide Despite the strong long-term themes supporting SMCI and a solid base of bullish investors, the stock has faced serious headwinds since reaching its 2024 peak. A critical report last year resurfaced concerns over accounting practices, echoing a 2018 SEC probe that resulted in fines and a temporary NASDAQ delisting. The fallout was swift: shares plunged nearly 85% at their lowest point. Investor confidence was further rattled by a delayed 10-K filing, raising fears of another potential delisting, while ongoing investigations by the DOJ and SEC cast an even darker cloud. The effect on SMCI's share price has been significant. As TipRanks data shows, SMCI's performance against the broader S&P 500 (SPX) benchmark has been lackluster to say the least. SMCI has lagged the S&P by over 40%. Operational challenges have added to the pressure. SMCI's most recent quarterly results fell short of expectations, with revenue coming in at $4.6 billion versus a forecasted $5 billion. Adjusted EPS dropped to $0.31 from $0.66 a year earlier, hit by inventory write-downs on older-generation GPUs and customer delays tied to the transition to NVIDIA's Blackwell architecture. Gross margins shrank to 9.7%, down 220 basis point s from the previous quarter, due to rising costs and a mix shift toward lower-margin hyperscale contracts. Meanwhile, a $2 billion convertible note offering raised dilution concerns, further weighing on sentiment. Robust Growth Prospects: A Bright Horizon Despite recent setbacks, SMCI has now addressed its accounting concerns, and its long-term growth outlook remains firmly intact, driven by the ongoing surge in AI infrastructure demand. Even with last quarter's top-line miss, revenue still climbed 19% year-over-year, with AI GPU platforms making up over 70% of total sales—a clear sign of strong adoption among enterprise clients and cloud providers. CEO Charles Liang emphasized SMCI's first-mover advantage with next-gen GPU platforms and its Datacenter Building Block Solutions (DCBBS), which are expected to power growth as customers transition to technologies like NVIDIA's Blackwell architecture starting in Q4 2025. The company is also expanding aggressively, building out facilities in Malaysia, Taiwan, and Europe to keep pace with global demand. Its upcoming DLC-2 liquid-cooling solution and strategic partnerships with NVIDIA and Ericsson on edge AI infrastructure further strengthen its competitive position in the $367 billion data center market. Reflecting this momentum, management is guiding for Q4 2025 revenue between $5.6 billion and $6.4 billion, with adjusted EPS of $0.40 to $0.50, signaling confidence in both margin recovery and production scale-up. A Bargain with Upside Potential At today's share price, SMCI trades at 23x this year's expected EPS of $2.08, a compelling multiple given its growth trajectory. At the same time, analysts forecast EPS growth of 34% in 2026 and 28% in 2027, which is to be driven by AI demand and improving supply chains. So SMCI's forward P/Es quickly fall to mid-teens below $50 per share, which means that as SMCI achieves these targets, investors are likely to chase the stock higher. So yes, risks remain, including rising competition and potential tariff impacts. Still, the broader AI and data center trends remain powerful tailwinds, with SMCI's leadership in high-efficiency servers and cooling systems aligning with market demand. Is SMCI Stock a Good Buy? Analyst sentiment on SMCI is currently mixed, reflecting a divide between those who view it as a value opportunity and those who remain cautious. The stock holds a Moderate Buy consensus, based on six Buy, six Hold, and two Sell ratings issued over the past three months. Notably, SMCI's average 12-month price target stands at $42.67, implying about 13% downside from current levels. This suggests that, unlike my more optimistic outlook, Wall Street isn't yet convinced the stock is on track to reclaim its previous highs. SMCI Set for Rebound as Wall Street Remains Unconvinced Despite recent volatility, SMCI continues to play a vital role in the AI infrastructure landscape, backed by strong fundamentals, accelerating demand, and an attractive valuation. Its leadership in next-generation server and cooling technologies, expanding global presence, and strategic partnerships position the company well for long-term growth. Now that its accounting concerns are resolved and margin pressures appear set to ease, SMCI looks poised to regain lost ground. While Wall Street's conviction in the stock remains lukewarm for now, the underlying story suggests meaningful upside for those willing to look past the near-term noise.

Nvidia Expects US License to Resume AI Chip Sales to China
Nvidia Expects US License to Resume AI Chip Sales to China

Bloomberg

time34 minutes ago

  • Bloomberg

Nvidia Expects US License to Resume AI Chip Sales to China

Good morning. Nvidia gets the nod from the US to resume AI chip sales to China. The EU will target American cars and bourbon in tariff countermeasures. And Rachel Reeves gives a major speech to the City of London tonight. Listen to the day's top stories. Nvidia plans to resume sales of its H20 AI chip to China based on assurances from Washington that such shipments would be approved, a dramatic reversal from the Trump administration's earlier stance. Nasdaq 100 futures rose after the announcement, while Asian shares wavered as traders awaited key US inflation data.

Jim Cramer Says He 'Wouldn't Bet Against' Amazon
Jim Cramer Says He 'Wouldn't Bet Against' Amazon

Yahoo

time37 minutes ago

  • Yahoo

Jim Cramer Says He 'Wouldn't Bet Against' Amazon

Inc. (NASDAQ:AMZN) is one of the stocks on Jim Cramer's radar. During the episode, Cramer discussed the company in detail, as he said: 'We're going to start with the daily chart of Amazon, which is Lang's (Bob Lang, founder of and the author of Know Your Options) favorite right now after its remarkable run over the past couple of months. Even after this move, Amazon's trading at $222 and change, down about 20 bucks from its all-time highs… A customer entering an internet retail store, illustrating the convenience of online shopping. Amazon (NASDAQ:AMZN) operates a global platform for retail, digital content, cloud computing, and advertising, and offers products through both first-party sales and third-party sellers. Moreover, the company provides devices, media, and services like Prime, AWS, and tools for creators, developers, and advertisers. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store